[与癌症相关的缓解症:一种未解决的疾病]
1Centre de recherche des Cordeliers, Inserm U1138, Sorbonne Université, Université Paris-Cité, Paris, France.
概括
与癌症相关的消耗综合征卡赫西亚 (Cachexia) 导致显著的死亡率. 这种情况涉及肌肉损失,疲劳和炎症,机制不明,目前没有治疗方法.
科学领域:
- 在瘤学瘤学.
- 代谢障碍 代谢障碍 代谢障碍
- 病理生理学 病理生理学
背景情况:
- 卡赫西亚是晚期癌症的严重并发症,导致显著的发病率和死亡率.
- 它的特点是不自主减肥,肌肉消耗和脂肪组织损失,可能导致死亡.
- 目前缺乏缓冲症的治疗方法.
研究的目的:
- 阐明癌症缓解症背后的复杂机制.
- 确定参与其诱导和进展的关键调解者.
- 了解与这种情况相关的多系统性损伤.
主要方法:
- 关于癌症缓解症的现有文献的审查.
- 对炎症,代谢和神经内分泌路径的分析.
- 研究瘤与宿主相互作用和器官间交叉通话.
主要成果:
- 吃症涉及复杂的症状相互作用,包括疲劳,炎症,疼痛,厌食症和抑郁症.
- 多系统性损伤会影响诸如肌肉,脂肪组织,大脑,免疫系统和胃肠道等器官.
- 疾病机制是由炎症,代谢和神经内分泌因素驱动的.
结论:
- 癌症缓冲症是一种多因素状况,机制不明.
- 对其驱动因素的进一步研究对于开发有效的治疗方法至关重要.
- 了解器官间交叉通话和调解器的作用是对抗这种消耗综合征的关键.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer
48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


